Erratum: Pathogenesis of and unifying hypothesis for idiopathic pouchitis (The American Journal of Gastroenterology (2009) 104 (1013-1023) DOI:10.1038/ajg.2008.127);Pathogenesis of and unifying hypothesis for idiopathic pouchitis

American Journal of Gastroenterology

Volumn 104, Issue 4, 2009, Pages 1013-1023

  Coffey, J Calvin ^a   Rowan, Fiachra ^a   Burke, John ^a   Dochery, Neil ^a   Kirwan, William O ^b   O'Connell, P Ronan ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b University College Cork   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ARACHIDONIC ACID; BILE ACID; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CYCLOOXYGENASE 2; HYDROGEN SULFIDE; ICOSANOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 8; LYMPHOTOXIN; NITRIC OXIDE; SHORT CHAIN FATTY ACID; SULFOMUCIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIGEN PRESENTATION; APOPTOSIS; BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; CELL LOSS; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOTOXICITY; DNA POLYMORPHISM; FECES IMPACTION; GENETIC SUSCEPTIBILITY; GLYCOPROTEIN SYNTHESIS; HUMAN; HYPOTHESIS; IDIOPATHIC DISEASE; ILEITIS; IMMUNOGENETICS; INTESTINE FLORA; INTESTINE ISCHEMIA; INTESTINE METAPLASIA; MUCOSA; MUCOSA INFLAMMATION; MUCOSAL IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SULFATE REDUCING BACTERIUM; ULCERATIVE COLITIS; ANAL CANAL; ANASTOMOSIS; BACTERIA; COLITIS, ULCERATIVE; COLOSTOMY BAG; DIFFERENTIAL DIAGNOSIS; GROWTH, DEVELOPMENT AND AGING; INTESTINE MUCOSA; METAPLASIA; MICROBIOLOGY; PATHOLOGY; POSTOPERATIVE COMPLICATION; POUCHITIS; PROCEDURES;

ANAL CANAL; ANASTOMOSIS, SURGICAL; ANTI-BACTERIAL AGENTS; BACTERIA; COLITIS, ULCERATIVE; COLONIC POUCHES; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTESTINAL MUCOSA; METAPLASIA; POSTOPERATIVE COMPLICATIONS; POUCHITIS;

EID: 65449145198     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.294     Document Type: Erratum

References (125)

1. Meagher AP, Farouk R, Dozois RR et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 131ftpatients. Br J Surg 1998;85:800-3.
2. O'Connell PR, Kelly KA, Pemberton JH. Motor function of the J-pouch and its significance for continence. World J Surg 1987;11:735-41.
3. O'Connell PR, Rankin DR, Weiland LH et al. Enteric bacteriology, absorption, morphology and emptying after ileal pouch-anal anastomosis. Br J Surg 1986;73:909-14.
4. Belliveau P, Trudel J, Vasilevsky CA et al. Ileoanal anastomosis with reservoirs: complications and long-term results. Can J Surg 1999;42:345-52.
5. Sandborn WJ, Tremaine WJ, Batts KP et al. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994;69:409-15.
6. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal in) ammation. Gastroenterology 2004;126:1518-32.
7. Tulchinsky H, Hawley PR, Nicholls J. Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 2003;238:229-34.
8. Sagar PM, Taylor BA, Godwin P et al. Acute pouchitis and deficiencies of fuel. Dis Colon Rectum 1995;38:488-93.
9. Schouten WR. Pouchitis. Mediators In) amm 1998;7:175-81.
10. Sagap I, Remzi FH, Hammel JP et al. Factors associated with failure in managing pelvic sepsis after ileal pouch-anal anastomosis (IPAA) - a multivariate analysis. Surgery 2006;140:691-703; discussion 703-4.
11. Sandborn WJ, Pardi DS. Clinical management of pouchitis. Gastroenterology 2004;127:1809-14.
12. Shen B, Goldblum JR, Hull TL et al. Clostridium diO cile-associated pouchitis. Dig Dis Sci 2006;51:2361-4.
13. Shen B, Lashner BA. Pouchitis: a spectrum of diseases. Curr Gastroenterol Rep 2005;7:404-11.
14. Stallmach A, Schmidt C. [Ileo pouch-anal anastomosis.]. Internist (Berl) 2007;48:606-12.
15. Pardi DS, Sandborn WJ. Systematic review: the management of pouchitis. Aliment Pharmacol er 2006;23:1087-96.
16. Mann SD, Pitt J, Springall RG et al. Clostridium diO cile infection - an unusual cause of refractory pouchitis: report of a case. Dis Colon Rectum 2003;46:267-70.
17. Vucelic B. [ erapy of in) ammatory bowel disease]. Med Arh 2002;56:37-45.
18. Kroesen AJ, Stockmann M, Ransco C et al. Impairment of epithelial transport but not of barrier function in idiopathic pouchitis after ulcerative colitis. Gut 2002;50:821-6.
19. Munoz-Juarez M, Pemberton JH, Sandborn WJ et al. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum 1999;42:117-20.
20. Mignon M, Stettler C, Phillips SF. Pouchitis - a poorly understood entity. Dis Colon Rectum 1995;38:100-3.
21. Yu ED, Shao Z, Shen B. Pouchitis. World J Gastroenterol 2007;13:5598-604.
22. Lohmuller JL, Pemberton JH, Dozois RR et al. Pouchitis and extraintestinal manifestations of in) ammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990;211:622-7;discussion 627-9.
23. Penna C, Tiret E, Kartheuser A et al. Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis. Br J Surg 1993;80:765-7.
24. Tjandra JJ, Fazio VW, Church JM et al. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis. Am J Surg 1993;165:322-5.
25. Abdelrazeq AS, Wilson TR, Leitch DL et al. Ileitis in ulcerative colitis: is it a backwash? Dis Colon Rectum 2005;48:2038-46.
26. Cheifetz A, Itzkowitz S. The diagnosis and treatment of pouchitis in in) ammatory bowel disease. J Clin Gastroenterol 2004;38:S44-50.
27. Rothenberger DA, Wiltz O. [Etiology of "pouchitis"]. Ann Chir 1993;47:1043-6.
28. Rubinstein MC, Fisher RL. Pouchitis: pathogenesis, diagnosis, and management. Gastroenterologist 1996;4:129-33.
29. Ruseler-van Embden JG, Schouten WR, van Lieshout LM. Pouchitis: result of microbial imbalance? Gut 1994;35:658-64.
30. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994;107:1856-60.
31. Meier R, Steuerwald M. Place of probiotics. Curr Opin Crit Care 2005;11:318-25.
32. Duffy M, O'Mahony L, Coffey JC et al. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum 2002;45:384-8.
33. Ohge H, Furne JK, Springfield J et al. Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005;48:469-75.
34. Ohge H, Takesue Y, Sueda T et al. [Fecal hydrogen sulfide: toxin? Or just odoriferous gas?]. Jpn J Antibiot 2005;58:193-9.
35. Lim M, Sagar P, Finan P et al. Dysbiosis and pouchitis. Br J Surg 2006;93:1325-34.
36. Ohge H, Furne JK, Springfield J et al. The effect of antibiotics and bismuth on fecal hydrogen sulfide and sulfate-reducing bacteria in the rat. FEMS Microbiol Lett 2003;228:137-42.
37. Florin T, Khalil D, Lenarczyck A et al. Re: Levine et al. Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 1998;93:2638.
38. Levine J, Ellis CJ, Furne JK et al. Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 1998;93:83-7.
39. Levine J, Furne JK, Levitt MD. Ashkenazi Jews, sulfur gases, and ulcerative colitis. J Clin Gastroenterol 1996;22:288-91.
40. Merrett MN. Ileal pouches: adaptation and in) ammation. Baillieres Clin Gastroenterol 1997;11:175-93.
41. de Silva HJ, Millard PR, Soper N et al. E1 ects of the faecal stream and stasis on the ileal pouch mucosa. Gut 1991;32:1166-9.
42. Heppell J, Belliveau P, Taillefer R et al. Quantitative assessment of pelvic ileal reservoir emptying with a semisolid radionuclide enema. A correlation with clinical outcome. Dis Colon Rectum 1987;30:81-5.
43. Smith FM, Co1 ey JC, Kell MR et al. A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch. Colorectal Dis 2005;7:563-70.
44. Meuwissen SG, Hoitsma H, Boot H et al. Pouchitis (pouch ileitis). Neth J Med 1989;35 (Suppl 1):S54-66.
45. Nasmyth DG, Godwin PG, Dixon MF et al. Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology 1989;96:817-24.
46. Komanduri S, Gillevet PM, Sikaroodi M et al. Dysbiosis in pouchitis: evidence of unique micro) oral patterns in pouch in) ammation. Clin Gastroenterol Hepatol 2007;5:352-60.
47. McLeod RS, Antonioli D, Cullen J et al. Histologic and microbiologic features of biopsy samples from patients with normal and inflamed pouches. Dis Colon Rectum 1994;37:26-31.
48. Onderdonk AB, Dvorak AM, Cisneros RL et al. Microbiologic assessment of tissue biopsy samples from ileal pouch patients. J Clin Microbiol 1992;30:312-7.
49. Chapman TM, Plosker GL, Figgitt DP. VSL#3 probiotic mixture: a review of its use in chronic in) ammatory bowel diseases. Drugs 2006;66:1371-87.
50. Cummings JH, Macfarlane GT, Macfarlane S. Intestinal bacteria and ulcerative colitis. Curr Issues Intest Microbiol 2003;4:9-20.
51. Cottone M, Orlando A, Modesto I. Postoperative maintenance therapy for inflammatory bowel disease. Curr Opin Gastroenterol 2006;22:377-81.
52. Kuhbacher T, Schreiber S, Runkel N. Pouchitis: pathophysiology and treatment. Int J Colorectal Dis 1998;13:196-207.
53. Stocchi L, Pemberton JH. Pouch and pouchitis. Gastroenterol Clin North Am 2001;30:223-41.
54. Bambury N, Co1 ey JC, Burke J et al. Sulphomucin expression in ileal pouches: emerging di1 erences between ulcerative colitis and familial adenomatous polyposis pouches. Dis Colon Rectum 2008;51:561-7.
55. Simon GL, Gorbach SL. The human intestinal micro) ora. Dig Dis Sci 1986;31:147S-62S.
56. Wischmeyer P, Pemberton JH, Phillips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993;68:978-81.
57. Clausen MR, Tvede M, Mortensen PB. Short-chain fatty acids in pouch contents from patients with and without pouchitis after ileal pouch-anal anastomosis. Gastroenterology 1992;103:1144-53.
58. de Silva HJ, Ireland A, Kettlewell M et al. Short-chain fatty acid irrigation in severe pouchitis. N Engl J Med 1989;321:1416-7.
59. Duffy M, Regan M, Harrington MG et al. Mucosal metabolism in ileal faecal and urinary reservoirs. Br J Surg 1998;85:804-8.
60. Kuisma J, Mentula S, Luukkonen P et al. Factors associated with ileal mucosal morphology and in) ammation in patients with ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2003;46:1476-83.
61. Christl SU, Scheppach W. Metabolic consequences of total colectomy. Scand J Gastroenterol Suppl 1997;222:20-4.
62. Sandborn WJ, Tremaine WJ, Batts KP et al. Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 1995;40:1474-83.
63. Kuisma J, Nuutinen H, Luukkonen P et al. Long term metabolic consequences of ileal pouch-anal anastomosis for ulcerative colitis. Am J Gastroenterol 2001;96:3110-6.
64. Hill MJ, Owen RJ. Faecal bile acids in pouch and pouchitis patients. Int J Colorect Dis 1989;4:205-29.
65. Hill MG. Bacteriology: pouchitis workshop. Int J Colorect Dis 1989;4:205-29.
66. Nasmyth DG, Johnston D, Williams NS et al. Changes in the absorption of bile acids after total colectomy in patients with an ileostomy or pouch-anal anastomosis. Dis Colon Rectum 1989;32:230-4.
67. Shepherd NA. Pouchitis and neoplasia in the pelvic ileal reservoir. Gastroenterology 1995;109:1381-3.
68. Shepherd NA, Healey CJ, Warren BF et al. Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut 1993;34:101-5.
69. Co1 ey JC, Bennett MW, Wang JH et al. Upregulation of Fas-Fas-L (CD95/CD95L)-mediated epithelial apoptosis - a putative role in pouchitis? J Surg Res 2001;98:27-32.
70. de Silva HJ, Jones M, Prince C et al. Lymphocyte and macrophage subpopulations in pelvic ileal pouches. Gut 1991;32:1160-5.
71. Chaussade S, Denizot Y, Valleur P et al. Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis. Gastroenterology 1991;100:1509-14.
72. Evgenikos N, Bartolo DC, Hamer-Hodges DW et al. Immunoglobulin G and albumin levels in whole gut lavage ) uid provide an objective measure of pouch ileitis. Br J Surg 2000;87:808-13.
73. Stallmach A, van Look M, Schei1 ele F et al. IgG, albumin, and sCD44 in whole-gut lavage ) uid are useful clinical markers for assessing the presence and activity of pouchitis. Int J Colorectal Dis 1999;14:35-40.
74. Herbst F, Ciclitira PJ, Talbot IC et al. Early changes of ileoanal pouch mucosa in patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2000;12:899-905.
75. de Silva HJ, Gatter KC, Millard PR et al. Crypt cell proliferation and HLA-DR expression in pelvic ileal pouches. J Clin Pathol 1990;43:824-8.
76. Fayad R, Brand MI, Stone D et al. Apoptosis resistance in ulcerative colitis: high expression of decoy receptors by lamina propria T cells. Eur J Immunol 2006;36:2215-22.
77. Iwamoto M, Koji T, Makiyama K et al. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 1996;180:152-9.
78. Iwamoto M, Makiyama K, Koji T et al. [Expression of Fas and Fas-ligand in epithelium of ulcerative colitis]. Nippon Rinsho 1996;54:1970-4.
79. Naugler KM, Baer KA, Ropeleski MJ. Interleukin-11 antagonizes Fas ligand-mediated apoptosis in IEC-18 intestinal epithelial crypt cells: role of MEK and Akt-dependent signaling. Am J Physiol Gastrointest Liver Physiol 2008;294:G728-37.
80. Strater J, Wellisch I, Riedl S et al. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 1997;113:160-7.
81. Kmiot WA, Youngs D, Tudor R et al. Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis. Br J Surg 1993;80:1445-9.
82. Shen B, Fazio VW, Remzi FH et al. Clinical features and quality of life in patients with different phenotypes of Crohn's disease of the ileal pouch. Dis Colon Rectum 2007;50:1450-9.
83. Shepherd NA, Hulten L, Tytgat GN et al. Pouchitis. Int J Colorectal Dis 1989;4:205-29.
84. O'Byrne JM, O'Connell PR, Nolan M et al. Morphology, crypt cell kinetics and histochemistry of ileal pouch mucosa: an experimental model. Int J Colorectal Dis 1996;11:52-5.
85. de Silva HJ, Millard PR, Kettlewell M et al. Mucosal characteristics of pelvic ileal pouches. Gut 1991;32:61-5.
86. Carraro PG, Talbot IC, Nicholls JR. Patterns of distribution of endoscopic and histological changes in the ileal resrvoir after restorative proctocolectomy for ulcerative colitis. Int J Colorectal Dis 1998;13:103-7.
87. Dhillon S, Loftus EV, Tremaine W et al. The natural history of surgery for ulcerative colitis a population based cohort. Am j Gastroenterol 2005;100:A819.
88. Kuhbacher T, Gionchetti P, Hampe J et al. Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis. Clin Exp Immunol 2001;123:395-401.
89. Campbell AP, Merrett MN, Kettlewell M et al. Expression of colonic antigens by goblet and columnar epithelial cells in ileal pouch mucosa: their association with in) ammatory change and faecal stasis. J Clin Pathol 1994;47:834-8.
90. Goldberg PA, Herbst F, Becket CG et al. Leukocyte typing, cytokine expression, and epithelial turnover in ileal pouch patients with ulcerative colitis and familial adenomatous polyposis. Gut 1996;38:549-53.
91. Malizia G, Calabrese A, Cottone M et al. Expression of leukocyte adesion molecules by mononulcear phagocytes in in) ammatory bowel disease. Gastroenterology 1991;100:150-9.
92. Patel RT, Pall AA, Adu D et al. Circulating soluble adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:1037-41.
93. Patel RT, Stokes R, Birch D et al. In) uence of total colectomy on serum antineutrophil cytoplasmic antibodies in in) ammatory bowel disease. Br J Surg 1994;81:724-6.
94. Stucchi AF, Shebani KO, Leeman SE et al. A neurokinin 1 receptor antagonist reduces an ongoing ileal pouch in) ammation and the response to a subsequent in) ammatory stimulus. Am J Physiol Gastrointest Liver Physiol 2003;285:G1259-67.
95. Aisenberg J, Legnani PE, Nilubol N et al. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol 2004;99:432-41.
96. Brett PM, Yasuda N, Yiannakou JY et al. Genetic and immunological markers in pouchitis. Eur J Gastroenterol Hepatol 1996;8:951-5.
97. Carter MJ, Di Giovine FS, Cox A et al. e interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 2001;121:805-11.
98. Facklis K, Plevy SE, Vasiliauskas EA et al. Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications. Dis Colon Rectum 1999;42:601-5;discussion 605-6.
99. Meier CB, Hegazi RA, Aisenberg J et al. Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor? Inflamm Bowel Dis 2005;11:965-71.
100. Shen B, Lashner B. Can we immunogenotypically and immunophenotypically profile patients who are at risk for pouchitis? Am J Gastroenterol 2004;99:442-4.
101. Levin KE, Pemberton JH, Phillips SF et al. Role of oxygen free radicals in the etiology of pouchitis. Dis Colon Rectum 1992;35:452-6.
102. Joelsson M, Andersson M, Bark T et al. Allopurinol as prophylaxis against pouchitis following ileal pouch-anal anastomosis for ulcerative colitis. A randomized placebo-controlled double-blind study. Scand J Gastroenterol 2001;36:1179-84.
103. Perbeck L, Lindquist K, Proano E et al. Correlation between fluorescein flowmetry and laser Doppler flowmetry. A study in the intestine (ileoanal pouch) in man. Scand J Gastroenterol 1990;25:520-4.
104. Sakaguchi M, Hosie KB, Gourevitch D et al. Laser Doppler assessment of human colonic blood flow. J Med Eng Technol 1990;14:188-9.
105. Veress B, Reinholt FP, Lindquist K et al. Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 1995;109:1090-7.
106. Scott AD, Phillips RK. Ileitis and pouchitis a0 er colectomy for ulcerative colitis. Br J Surg 1989;76:668-9.
107. Shepherd NA, Jass JR, Duval I et al. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987;40:601-7.
108. Humphries DE, Silbert CK, Silbert JE. Glycosaminoglycan production by bovine aortic endothelial cells cultured in sulfate-depleted medium. J Biol Chem 1986;261:9122-7.
109. Liau YH, Murty VL, Slomiany A et al. Role of sulfation in the processing of gastric mucins. J Physiol Pharmacol 1991;42:357-66.
110. Tyree B, Hassell JR, Hascall VC. Altered synthesis of heparan sulfate proteoglycans at low sulfate concentration. Arch Biochem Biophys 1986;250:202-10.
111. Nieuw Amerongen AV, Bolscher JG, Bloemena E et al. Sulfomucins in the human body. Biol Chem 1998;379:1-18.
112. Deplancke B, Finster K, Graham WV et al. Gastrointestinal and microbial responses to sulfate-supplemented drinking water in mice. Exp Biol Med (Maywood) 2003;228:424-33.
113. Levitt MD, Springfield J, Furne J et al. Physiology of sulfide in the rat colon: use of bismuth to assess colonic sulfide production. J Appl Physiol 2002;92:1655-60.
114. Kmiot WA, Williams MR, Keighley MR. Pouchitis following colectomy and ileal reservoir construction for familial adenomatous polyposis. Br J Surg 1990;77:1283.
115. Lammers KM, Helwig U, Swennen E et al. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 2002;97:1182-6.
116. Abdelrazeq AS, Lund JN, Leveson SH. Pouchitis-associated pyoderma gangrenosum following restorative proctocolectomy for ulcerative colitis. Eur J Gastroenterol Hepatol 2004;16:1057-8.
117. Abi Karam G, Awada H, Nasr F et al. Ileal pouchitis and arthritis. Semin Arthritis Rheum 2003;33:215.
118. Achkar JP, Al-Haddad M, Lashner B et al. Di1 erentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005;3:60-6.
119. Teixeira WG, da Silva JH, Teixeira MG et al. Pouchitis: extracolonic manifestation of ulcerative colitis? Rev Hosp Clin Fac Med Sao Paulo 1999;54:155-8.
120. Gionchetti P, Rizzello F, Poggioli G et al. Probiotic therapy to prevent pouchitis onset. Dis Colon Rectum 2005;48:1493;author reply 1493-4.
121. Gionchetti P, Rizzello F, Poggioli G et al. Oral budesonide in the treatment of chronic refractory pouchitis. Aliment Pharmacol Ther 2007;25:1231-6.
122. Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients a0 er ileal pouch-anal anastomoses. World J Surg 2000;24:851-6.
123. Hurst RD, Molinari M, Chung TP et al. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996;131:497-500;discussion 501-2.
124. Mowschenson PM, Critchlow JF, Peppercorn MA. Ileoanal pouch operation: long-term outcome with or without diverting ileostomy. Arch Surg 2000;135:463-5;discussion 465-6.
125. Merrett MN, Soper N, Mortensen N et al. Intestinal permeability in the ileal pouch. Gut 1996;39:226-30.